Literature DB >> 32162331

Cervicofacial actinomycosis.

Katrice M Karanfilian1, Monica N Valentin1, Rajendra Kapila2, Chinmoy Bhate1, Mahnaz Fatahzadeh3, Giuseppe Micali4, Robert A Schwartz1.   

Abstract

Cervicofacial actinomycosis is an uncommon, chronic, suppurative, and granulomatous bacterial infection. It is often of dental origin and tends to mimic other dental infections, granulomatous disorders, and cancers. The initial diagnostic workup, predicated upon imaging and tissue biopsies, is frequently nonspecific. A definitive diagnosis is usually rendered only after surgical excision and histologic examination of the cervicofacial mass. We propose a classification of three stages: localized infection without sinus involvement, localized infection with sinus involvement, and disseminated infection, to facilitate recognition, diagnosis, and early aggressive treatment. Untreated infection may be life-threatening. Therapy may require long-term antibiotics; however, many cases may also necessitate complete surgical excision.
© 2020 the International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32162331     DOI: 10.1111/ijd.14833

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  6 in total

1.  Mandibular Actinomycosis Disguised as a Periapical Lesion.

Authors:  Shalini Nair; Shahnaz Mahaboob; Vikas Kuruvilla; Monicah Roy; Shereefa Fareesh
Journal:  Cureus       Date:  2022-08-14

2.  Actinomycosis of the Nasal Septum: A Rare Entity.

Authors:  Catarina Lombo; Carlos Matos; Fausto Fernandes
Journal:  Cureus       Date:  2021-11-11

3.  A rare case of Mycobacterium Chelonae infection in an immunocompromised adult with cavernous sinus syndrome.

Authors:  Ye Li; Le Zhang; Chunhui Li; Xuelun Zou; Yi Zeng; Zhiping Hu; Bo Xiao; Lili Long
Journal:  CNS Neurosci Ther       Date:  2022-02-15       Impact factor: 5.243

4.  Sonication versus the conventional method for evaluation of the dental microbiome: a prospective pilot study.

Authors:  Oliver Wagendorf; Peter Menzel; Rolf Schwarzer; Norbert Neckel; Saskia Preissner; Max Heiland; Susanne Nahles
Journal:  BMC Oral Health       Date:  2022-08-12       Impact factor: 3.747

Review 5.  Oral and Maxillo-Facial Manifestations of Systemic Diseases: An Overview.

Authors:  Saverio Capodiferro; Luisa Limongelli; Gianfranco Favia
Journal:  Medicina (Kaunas)       Date:  2021-03-16       Impact factor: 2.430

6.  Antimicrobial Susceptibility of Clinical Oral Isolates of Actinomyces spp.

Authors:  Alexandra Wolff; Arne C Rodloff; Paul Vielkind; Toralf Borgmann; Catalina-Suzana Stingu
Journal:  Microorganisms       Date:  2022-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.